Healthpeak Properties (NYSE:DOC – Free Report) had its price target raised by Wedbush from $22.00 to $25.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has an outperform rating on the real estate investment trust’s stock. Wedbush also issued estimates for Healthpeak Properties’ Q3 2024 earnings at $0.44 EPS and Q4 2024 earnings at $0.45 EPS.
A number of other analysts have also recently issued reports on the stock. Royal Bank of Canada raised their target price on shares of Healthpeak Properties from $21.00 to $22.00 and gave the stock an outperform rating in a research note on Wednesday, April 10th. Scotiabank boosted their price objective on Healthpeak Properties from $22.00 to $23.00 and gave the stock a sector outperform rating in a report on Thursday, May 16th. BNP Paribas raised Healthpeak Properties from a neutral rating to an outperform rating and upped their target price for the company from $19.00 to $21.00 in a research report on Friday, April 26th. JPMorgan Chase & Co. lifted their price target on Healthpeak Properties from $19.00 to $21.00 and gave the stock a neutral rating in a report on Thursday, May 16th. Finally, Mizuho reaffirmed a buy rating and issued a $22.00 price objective on shares of Healthpeak Properties in a report on Monday, April 22nd. One analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of Moderate Buy and an average target price of $20.64.
Check Out Our Latest Research Report on DOC
Healthpeak Properties Price Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23). Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. The business had revenue of $695.50 million for the quarter, compared to analyst estimates of $665.11 million. During the same period in the previous year, the firm posted $0.45 earnings per share. The firm’s revenue was up 27.5% compared to the same quarter last year. On average, analysts predict that Healthpeak Properties will post 1.79 EPS for the current year.
Healthpeak Properties Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Investors of record on Monday, August 5th will be given a dividend of $0.30 per share. The ex-dividend date is Monday, August 5th. This represents a $1.20 annualized dividend and a dividend yield of 5.52%. Healthpeak Properties’s dividend payout ratio is 342.86%.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the company. Parallel Advisors LLC lifted its position in shares of Healthpeak Properties by 274.6% during the 4th quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock worth $54,000 after buying an additional 2,985 shares during the last quarter. Quadrant Capital Group LLC lifted its holdings in shares of Healthpeak Properties by 645.4% in the fourth quarter. Quadrant Capital Group LLC now owns 9,646 shares of the real estate investment trust’s stock worth $128,000 after acquiring an additional 8,352 shares during the last quarter. Stratos Wealth Partners LTD. bought a new position in shares of Healthpeak Properties in the fourth quarter worth about $134,000. Koshinski Asset Management Inc. acquired a new stake in shares of Healthpeak Properties in the 4th quarter valued at approximately $146,000. Finally, Sapient Capital LLC bought a new stake in shares of Healthpeak Properties during the 4th quarter valued at approximately $152,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More
- Five stocks we like better than Healthpeak Properties
- Comparing and Trading High PE Ratio Stocks
- First Solar Stock: The Dawn of a New Rally in Share Prices
- The Most Important Warren Buffett Stock for Investors: His Own
- Mastercard Stock’s Q2 Financial Results Outshine Competitors
- Airline Stocks – Top Airline Stocks to Buy Now
- Tobacco Giant’s Shares Fall on EPS Miss, Lackluster Pouch Gains
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.